Recently, Gwen Nichols, MD, Chief Medical Officer at LLS, shared her perspectives with STAT News on the urgent need to bring the promise of precision medicine to children with cancer. “Children with cancer are not benefiting enough from the progress we are making,” writes Dr. Nichols. Here at LLS, we’re calling for a full-scale renaissance in pediatric drug development and care to address this pressing challenge. The LLS Children’s Initiative is leading the charge by taking on children’s cancer through every facet of our mission. Learn how we plan to realize progress for our youngest, most vulnerable patients on STAT News here and be sure to follow @DrGwenNichols in action on Twitter.